Ser800

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Ser800 - STXBP5L (human)

Site Information
sAACMEIsLPVTTEE SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 34668139

In vivo Characterization
Methods used to characterize site in vivo:	[32P] bio-synthetic labeling ( 1 ) , mass spectrometry ( 1 ) , mutation of modification site ( 1 )
Disease tissue studied:	pancreatic cancer ( 1 ) , pancreatic carcinoma ( 1 )
Relevant cell line - cell type - tissue:	293FT ( 1 ) , INS-1 (pancreatic) ( 1 )

Upstream Regulation
Treatments:	phorbol_ester ( 1 )

Downstream Regulation
Effects of modification on STXBP5L:	protein degradation ( 1 )

References
1	Bhatnagar S, et al. (2014) Phosphorylation and Degradation of Tomosyn-2 De-represses Insulin Secretion. J Biol Chem 289, 25276-86 25002582 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.